The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH Update on Myelofibrosis: What Are the Outcomes After Ruxolitinib Discontinuation? What Is the Additional Benefit of Parsaclisib & Ruxolitinib? Does LSD1 Improve Symptoms and OS?

125 views
March 8, 2021
Comments 0
Login to view comments. Click here to Login